Search

everythinglearnresearchcommunity

for

Search:↓

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Trichoscopy is a useful and affordable tool for diagnosing Alopecia areata.

AI can accurately measure hair loss severity in alopecia areata.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

The N-K GM Series offers a new method to reduce aflatoxin poisoning and cancer, improving health and saving costs in affected regions.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Enhancing Tregs can protect against alopecia areata.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Botulinum toxin type A injections are not effective for severe alopecia areata.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

The new method improves accuracy in segmenting scalp tissue layers.

The study found that Temporal Triangular Alopecia often starts in early childhood, mainly affects the left side of the scalp, and has no effective treatment except surgery.

People with autism are more likely to develop alopecia areata than those without autism.

Hair transplantation effectively treated a bald patch in an 18-year-old woman with Temporal Triangular Alopecia.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

A yeast-based test can detect the steroid methyltestosterone in urine longer than traditional methods.

Poor air quality increases the risk of atopic dermatitis in Taiwan.

ITK inhibitors may effectively treat alopecia areata.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Dutasteride improved both hair loss and acne in two young men.